Carregant...

Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3

BACKGROUND AND AIMS: Having a body mass index above or equal to 30 kg/m(2) in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to treatment with interferon and ribavirin, but details regarding the mechanisms whereby obesity reduces the efficacy of therapy re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Alsiö, Åsa, Rembeck, Karolina, Askarieh, Galia, Christensen, Peer Brehm, Färkkilä, Martti, Langeland, Nina, Rauning Buhl, Mads, Pedersen, Court, Mørch, Kristine, Haagmans, Bart L., Nasic, Salmir, Westin, Johan, Hellstrand, Kristoffer, Norkrans, Gunnar, Lagging, Martin
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360051/
https://ncbi.nlm.nih.gov/pubmed/22655053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0037521
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!